Back to News
Market Impact: 0.15
Wall Street Analysts Think Sagimet Biosciences Inc. (SGMT) Could Surge 168.24%: Read This Before Placing a Bet
Source: zacks.com
Analyst InsightsAnalyst EstimatesHealthcare & Biotech
Sagimet Biosciences' consensus price target implies 168.2% upside, but the article cautions that price targets are not very effective predictors. An upward trend in earnings estimate revisions may support near-term gains; no target price, revision magnitude, or market reaction is provided.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.10
Ticker Sentiment
SGMT0.30
More News
- The real test for Moderna’s cancer vaccine isn’t about beating Keytruda. It’s keeping cancer from coming back in the long term.
- Oncologists Cheer Melanoma Data
- SpaceX bear flips to big bull because of AI business. Analyst now sees 70% gain
- Vertex reports positive IgAN trial data, FDA decision due Nov. 30
- Williams Trading cuts Deckers Outdoor stock price target on weak DTC trends
- Investing.com’s stocks of the week